Latest Abide Therapeutics Stories
SAN DIEGO, Nov.
SAN DIEGO, July 29, 2014 /PRNewswire/ -- Abide Therapeutics announced today the appointment of Nancy Thornberry to its board
Abide Therapeutics Announces Strategic Drug Discovery Collaboration with Celgene Corporation to Advance Treatment Paradigm for Patients with Immune Disorders
SAN DIEGO and PRINCETON, N.J., Feb.